Home About Us Contact Us

 

Table of Content Volume 16 Issue 1 - October 2020

 

A study of complications and mortality in acute myocardial infarction among diabetic and non diabetic patients

 

Sham P Toshniwal1, Sanjay B Jagtap2*, Dhakne Anand3, Khan Aref Yousuf4

 

1Assistant Professor, 2Associate Professor, 3,4Junior Resident, Department of Medicine, Vilasrao Deshmukh Government Institute of Medical science, Latur, Maharashtra, INDIA.

Email: arefkhan91@yahoo.in

 

 

REFERENCES

  1. DIAMOND Project Group Incidence and trends of childhood type 1 diabetes worldwide 1990– 1999. Diabet Med. 2006;23:857–866.
  2. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.
  3. Nathan D.M., Meigs.J., Singer D.E., ―The Epidemiology of Cardiovascular Disease in Type-2 Diabetes Mellitus: How Sweat it is...Or is it‖The Lancet 1997, 350 (s1): s14 – s18
  4. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–393.
  5. Ahmed I, Goldstein BJ. Cardiovascular risk in the spectrum of type 2 diabetes mellitus. Mt Sinai J Med.2006;73:759–768.
  6. Abraham TM, Pencina KM, Pencina MJ, Fox CS. Trends in diabetes incidence: the Framingham heart study.Diab Care. 2015;38:482–487.
  7. The World Health Report, 2002: Reducing Risks, Promoting Healthy Life. World Health Organization; Geneva: 2002.
  8. Malmberg K, Ryden L, Efendic S. et al. Randomized trial of insulin‐glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 19952657–65.
  9.  Mak.K.H., Granger C.B., Miller D.P., et al. ― Influence of Diabetes Mellitus on Clinical Outcome in the thrombolytic era of Acute Myocardial Infarction – GUSTO – 1 Investigations‖ J.Am.Coll.Cardiol 1997; 30 : 171-179.
  10. Kannel W.B., Abbott R.D., ―Incidence and Prognosis of Unrecongnised Myocardial Infarction: An Update on the Framingham study‖ N.Engl.J.Med 1984; 311: 1144-7.
  11. Soler N.G., Bennett M., Pentecost B.L., et al. ― Myocardial Infarction in Diabetics‖ Q..J.Med 1975; 173: 125-32.
  12. Hong, Y.J., Jeong, M.H., Choi, Y.H., Song, J.A., Ahmed, K., Kim, D.H., Lee, K.H., Lee, M.G., Park, K.H., Sim, D.S., Yoon, N.S., Yoon, H.J., Kim, K.H., Park, H.W., Kim, J.H., Ahn, Y., Cho, J.G., Park, J.C. and Kang, J.C. (2011) Relationship between Microalbuminuria and Vulnerable Plaque Components in Patients with Acute Coronary Syndrome and with Diabetes Mellitus. Virtual Histology- Intravascular Ultrasound. Circulation Journal, 75, 2893-2901.
  13. Turner R.C., Millns H., Neil H.A.W., et al. ―Risk Factors for Coronary Artery Disease in Non-insulin Dependent diabetes Mellitus: United Kingdom Prospective Diabetes Study (UKPDS:23)‖ BMJ March 1998; 316: 823 – 828.
  14. Barett – Connor ; Barbara A., Wingard L., et al. ―Why is Diabetes mellitus a Stronger Risk Factor for Fatal Ischaemic Heart Disease in women than in Men‖ – The Rancho Bernardo Study‖ JAMA 1991; 265(5) : 627-631.
  15. Y. Juilliere, J.P. Cambou, V. Bataille, et al..Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry Rev Esp Cardiol, 65 (2012), pp. 326-333.
  16. Stamler J, Vaccaro O, Neaton J D. et al. Diabetes, other risk factors, and 12‐yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 199316434– 444.
  17. Kannel W B, McGee D L. Diabetes and cardiovascular disease: the Framingham Study. JAMA19792412035–2058.
  18. Miettinen H, Lehto S, Salomaa V. et al. Impact of diabetes on mortality after the first myocardial infarction: the FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 19982169–75.